Product analysis
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Ingredient Transparency100
Value For Money100
Customer Satisfaction91
Product Focus60
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.23
- Customer rating
- 4.7 · 9,496 ratings
Goals
Full Spectrum Vitamin K2 offers focused support for activation of bone proteins. Its separately identified 100 mcg of MK-7 supplies the clearest bone-related contribution. The additional 500 mcg vitamin K2 declaration has unresolved preparation identity and should not be treated as another 500 mcg of MK-7.
Full Spectrum Vitamin K2 has a narrow heart-health fit related to arterial stiffness. Its separately declared 100 mcg MK-7 provides the relevant connection, at a lower amount than the supplied long-term comparison. The separate 500 mcg MK-4 declaration adds no supported benefit for this specific goal in the supplied facts.
Full Spectrum Vitamin K2 offers limited, targeted support for arterial flexibility through its separately declared 100 mcg of MK-7. The additional 500 mcg of MK-4 has a different form and does not strengthen that specific connection in the supplied assessment. The two declarations should remain separate when comparing the product's cardiovascular fit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin K2 (MK-4) | 500 mcg | |
Vitamin K2 (Menaquinone-7) | 100 mcg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
- Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
- Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
- Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
- The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
- Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
- Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
- The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
- Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
- Vitamin K status and cognitive function in healthy older adults.
- High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
- Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.